期刊文献+

改良侧通道Fontan手术在小儿复杂先天性心脏病中的应用 被引量:2

Application of Modified Lateral Tunnel Fontan Procedure on Complex Congenital Heart Disease in Children
下载PDF
导出
摘要 目的总结改良侧通道Fontan手术纠治小儿危重复杂先天性心脏病的经验,探讨该手术方法的优越性。方法自1999年3月至2008年8月我院共对86例复杂型心内畸形患者施行心内板障侧通道Fontan手术,男47例,女39例;年龄1.9~11.5岁,平均年龄4.7岁;体重8.6~52.0kg,平均体重17.0kg。病种为无脾综合征33例,多脾综合征17例,三尖瓣闭锁(TA)11例,房室连接不一致的右心室双出口(DORV)11例,完全性大动脉错位(D-TGA)合并肺动脉狭窄8例,矫正性大动脉错位(cTGA)5例,Ebstein’畸形1例。术前分别行单侧双向上腔静脉肺动脉吻合术(BSCPA),双侧双向上腔静脉肺动脉吻合术和半-Fontan手术(hemi-Fontan opertiong);二次手术时间间隔0.7~7.8年(3.6±2.9年)。术中采用心内板障侧通道Fontan手术(LT组,47例)和改良心内板障侧通道Fontan手术(M-LT组,39例)方法连接下腔静脉的血引流入右肺动脉,部分完成二期改良Fontan手术。结果两组共死亡7例(9%),LT组死亡5例,M-LT组死亡2例,差异无统计学意义(χ2=0.865,P=0.448)。在分期改良Fontan手术中,M-LT组患者术前行BSCPA术明显多于LT组。术后仍有22例患者发生低心排血量综合征,其中肾功能受损导致无尿而行腹膜透析13例,透析2~5d后尿量恢复。术后LT组的心律失常患者明显多于M-LT组(χ2=8.763,P=0.003),置胸腔引流管时间LT组明显长于M-LT组(t=2.970,P=0.003)。门诊随访3个月~8年,无1例死亡。M-LT组随访33例(85%),LT组随访39例(83%),均未出现严重的并发症,患者活动能力明显改善。结论改良侧通道Fontan手术有一定的优越性,不失为一种提高手术成功率、减少术后并发症的改良方法。 Objective To summarize the treatment experiences of Modified lateral tunnel(LT) Fontan operation on complex congenital heart disease in children and investigate the advantages of this operation. Methods From March 1999 to August 2008,86 patients with cynosis complex congenital heart disease underwent LT Fontan operation in our hospital. There were 47 male and 39 female aged 1.9-11.5 years with a mean age of 4.7 years and weighed 8.6-52.0 kg with a mean weight of 17.0 kg. There were 33 cases with asplenia syndrome,17 cases with polysplenia syndrome,11 cases with tricuspid atresia(TA),11 cases with double outlet right ventricle(DORV) of atrioventricular discordance,8 cases with complete transposition of great arteries(D -TGA) complicated with pulmonary stenosis,5 cases with corrected transposition of great arteries(cTGA) and 1 case with Ebstein's anomaly. Unilateral superior bidirectional superior cavopulmonary anastomosis(BSCPA),bilateral bidirectional superior cavopulmonary anastomosis and hemi-Fontan opertion were done before operatipon. The time between two operations was 0.7-7.8 years(3.6±2.9 years). LT Fontan operation(LT group,47cases) and Modified LT Fontan operation(M-LT group,39cases) were used in operation to drain blood from inferior vena cava to right pulmonary artery. Partly completed second-stage M-LT Fontan operation. Results There were 7 deaths in two groups(9%),5 in LT group and 2 in M-LT group. There was no statistical significance(χ^2=0.865,P=0.448). In stage-modified LT Fontan operation,there were significantly more cases who had BSCPA operation preoperatively in M-LT group than that in LT group. Twenty-two cases had low cardiac output syndrome after operation,13 cases underwent peritoneal dialysis because of renal dysfunction,and their urine volume recovered after 2-5 days' dialysis. There were significantly more cases who had arrhythmia in LT group than that in M-LT group(χ^2=8.763,P=0.003). The time of chest drainage was longer in LT group than that in M-LT group(t=2.970,P=0.003). The follow-up time was 3 months-8 years. No death was found. In M-LT group 33(85%) cases were followed up and in LT group 39(83%)cases were followed up. No severe complication was found. Patients' activity ability improved significantly. Conclusion The M-LT Fontan operation is an advanced operation to improve the success rate of operation and reduce postoperative complications.
出处 《中国胸心血管外科临床杂志》 CAS 2009年第6期435-439,共5页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 上海市科学技术委员会"科技攻关"资助项目(074119516)~~
关键词 复杂先天性心脏病 改良FONTAN手术 侧通道 Complex congenital heart disease Modified Fontan operation Lateral tunnel
  • 相关文献

参考文献14

  • 1郑景浩,徐志伟,苏肇伉,丁文祥.二期Fontan术治疗小儿复杂先天性心脏病[J].中华胸心血管外科杂志,2007,23(2):97-99. 被引量:4
  • 2Podzolkov VP, Zaets SB, Chiaureli MR, et al. Comparative assessment of Fontan operation in modifications of atriopulmonary and total cavopulmonary anastomoses. Eur J Cardiothorac Surg, 1997,11(3) : 458-465.
  • 3Petrossian E, Thompson LD, Hanley FL. Extracardiae conduit variation of the Fontan procedure. Adv Card Surg, 2000, 12: 175-198.
  • 4Stamm C, Friehs I, Mayer JE Jr, et al. Long-term results of the lateral tunnel Fontan operation. .1 Thorac Cardiovasc Surg, 2001,121(1): 28-41.
  • 5Kumar SP, Rubinstein SC, Simsic JM, et al. Lateral tunnel versus extraeardiac conduit fontan procedure: a concurrent comparison. Ann Thorac Surg, 2003,76(5):1389-1397.
  • 6Driscoll DJ. Long-term results of the Fontan operation. Pediatr Cardiol, 2007, 28(6):438-442.
  • 7Lee JR, Kwak J, Kim KC, et al. Comparison of lateral tunnel and extracardiac conduit Fontan procedure. Interact Cardiovasc Thorac Surg, 2007, 6(3):328-330.
  • 8Hirsch JC, Ohye RG, Devaney EJ, et al. The lateral tunnel Fontan procedure for hypoplastic left heart syndrome: results of 100 consecutive patients. Pediatr Cardiol,2007,28(6) :426-432.
  • 9Alphonso N, Baghai M, Sundar P, et al. Intermediate-term outcome following the fontan operation: a survival, functional and risk-factor analysis. Eur J Cardiothorac Surg, 2005, 28(4) : 529-535.
  • 10Morales DL, Dibardino DJ, Braud BE,et al. Salvaging the failing Fontan: lateral tunnel versus extracardiac conduit. Ann Thorac Surg, 2005, 80(4):1445-1451.

二级参考文献10

  • 1Kaulitz R, Ziemer G, Luhmer I, et al. Modified Fontan operation in functionally univentricular hearts: preoperative risk factors and intermediate resuits. J Thorac Cardiovasc Surg, 1996,112:658-664.
  • 2Norwood W1, Jacobs ML. Fontan's procedure in two stages. Am J Surg,1993,166:548 - 551.
  • 3Manning PB, Mayer JE, Wemovsky G, et al. Staged operation to Fontan increases the incidence of sinoatrial node dysfunction. J Thorac Carttiovasc Surg, 1996,111:833-840.
  • 4Humes RA, Feldt RH, Porter CJ, et al. The modified Fontan procedure for asplenia and polysplenia syndromes. J Thorac Cardiovasc Surg, 1988,92:212 - 218.
  • 5Nakano T, Kado H, Ishikawa S, et al. Midterm sttrgical results of total cavopulmonary connection: clinical advantages of the extracardiac conduit method. J Thorac Cardiovasc Surg, 2004,127:730 - 737.
  • 6Tokurmga S, Kado H, Lmoto Y, et al. Total cavopulmonary connection with an extracardiac conduit: experience with 100 patients. A Thorac Surg, 2002,73:76 - 80.
  • 7Alexi-Meskishvili V, Ovroutski S, Ewert P, et al. Optimal conduit size for extracardiac fontan operation. Eur J Cardiothorac Surg, 2000,18:690-695.
  • 8Kreutzer C, Schlichter AJ, Simon JL, et al. A new method for reliable fenestration in extracardiac conduit Fontan operations. A Thorac Surg, 2003, 75 : 1657 - 1659.
  • 9Aeba R, Katogi T, Hashizume K, et al. Individualized total cavopulmonary connection technique for patients with asplenia syndrome. Ann Thorac Surg, 2002,73:1274 - 1280.
  • 10Gundry S, Hess H, Black M, et al. Extracardiac conduit Fontan procedure: early and intermediate results. EurJ Cardiothorac Surg, 2000,17:648 - 654.

共引文献3

同被引文献34

  • 1孙立军,江菊芬,郑敏文,刘莹.复杂性先天性心脏病影像学诊断的综合评估[J].放射学实践,2005,20(2):124-127. 被引量:8
  • 2顾复生.经皮介入治疗心脏病的进展和疑惑[J].心脑血管病防治,2006,6(4):205-207. 被引量:2
  • 3Ovaert C, Thijs D, Dewolf D. The effect of bosentan in patients with a failing Fontan circulation. Cardiol Young, 2009, 19(4): 331-339.
  • 4Schuuring MJ, Vis JC, Bouma BJ, et al. Rationale and design of a trial on the role of bosentan in Fontan patients: improvement of exercise capacity? Contemp Clin Trials, 2011, 32(4): 586-591.
  • 5Tomita H, Yamada O, Ohuchi H, et al. Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiol Young, 2001, 11(1): 62-66.
  • 6Gewillig M. The Fontan circulation. Heart, 2005, 91(6): 839-846.
  • 7Mertens L, Hagler DJ, Sanuer U, et al. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg, 1988, 115(5): 1063-1073.
  • 8Ishida H, Kogaki S, Ichimori H, et al. Overexpression of endo- thelin-1 and endothelin receptors in the pulmonary arteries of failed Fontan patients. Int J Cardiol, 2012, 159(1): 34-39.
  • 9Hebert A, Jensen AS, ldorn L, et al. The effect of bosentan on exercise capacity in Fortran patients; rationale and design for the TEMPO study. BMC Cardiovasc Disord, 2013. doi: 10.1186/1471- 2261-13-36.
  • 10Jasmin JF, Lucas M, Cernacek P, et al. Effectiveness of a nonselec- tive ET(A/B) and a selective ET(A) antagonist in rats with monocro- taline-induced pulmonary hypertension. Circulation, 2001, 103(2): 314-318.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部